- Home
- WHLR vs BDRX Comparison
WHLR vs BDRX Comparison
Compare WHLR & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WHLR | BDRX |
|---|---|---|
| Founded | 2011 | 2000 |
| Country | United States | United Kingdom |
| Employees | 56 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3M | 1.8M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | WHLR | BDRX |
|---|---|---|
| Price | $1.44 | $0.84 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 161.6K | 106.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.01 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.65 | $0.79 |
| 52 Week High | $10.05 | $11.88 |
Technical Indicators
Market Signals| Indicator | WHLR | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 36.28 | 28.25 |
| Support Level | N/A | $0.79 |
| Resistance Level | $2.25 | $1.29 |
| Average True Range (ATR) | 0.19 | 0.07 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 1.25 | 4.57 |
Price Performance
Historical ComparisonAbout WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.